ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
5.75
-0.08 (-1.37%)
At close: Apr 28, 2026, 4:00 PM EDT
5.64
-0.11 (-1.91%)
After-hours: Apr 28, 2026, 5:37 PM EDT
ImageneBio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Revenue | 0.8 | 3.5 | 7.96 |
| Revenue Growth (YoY) | -77.14% | -56.04% | - |
| Gross Profit | 0.8 | 3.5 | 7.96 |
| Selling, General & Admin | 20.73 | 8.39 | 7.96 |
| Research & Development | 28.53 | 32.11 | 21.93 |
| Operating Expenses | 49.25 | 40.5 | 29.89 |
| Operating Income | -48.45 | -37 | -21.93 |
| Interest & Investment Income | 2.04 | 0.37 | 1.19 |
| Other Non Operating Income (Expenses) | 0.72 | 0.07 | -0.14 |
| Pretax Income | -45.7 | -36.56 | -20.87 |
| Income Tax Expense | -0.35 | 0.01 | 0.28 |
| Net Income | -45.35 | -36.57 | -21.15 |
| Preferred Dividends & Other Adjustments | 7.05 | 11.82 | 10.89 |
| Net Income to Common | -52.4 | -48.38 | -32.04 |
| Shares Outstanding (Basic) | 5 | 2 | 321 |
| Shares Outstanding (Diluted) | 5 | 2 | 321 |
| Shares Change (YoY) | 148.16% | -99.32% | - |
| EPS (Basic) | -9.64 | -22.10 | -0.10 |
| EPS (Diluted) | -9.64 | -22.10 | -0.10 |
| Free Cash Flow | -47.84 | -21.32 | -18.54 |
| Free Cash Flow Per Share | -8.81 | -9.74 | -0.06 |
| Gross Margin | 100.00% | 100.00% | 100.00% |
| Operating Margin | -6056.38% | -1057.14% | -275.37% |
| Profit Margin | -6549.38% | -1382.40% | -402.39% |
| Free Cash Flow Margin | -5980.50% | -609.11% | -232.83% |
| EBITDA | -48.05 | -35.86 | -19.52 |
| EBITDA Margin | - | - | -245.15% |
| D&A For EBITDA | 0.4 | 1.14 | 2.41 |
| EBIT | -48.45 | -37 | -21.93 |
| EBIT Margin | - | - | -275.37% |
Source: S&P Capital IQ. Standard template.
Financial Sources.